A. Schobel
Chief Tech/Sci/R&D Officer presso AQUESTIVE THERAPEUTICS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
A.
Mark Schobel is currently the Director at Cecilian Partners, LLC.
He is also the Chief Technology & Innovation Officer at Aquestive Therapeutics, Inc. since 2015.
Additionally, he holds the position of Head-Public Relations at MonoSol LLC.
In the past, Mr. Schobel worked as the Principal at Pharmaceutical Formulations, Inc. and Warner-Lambert Co. He was also the Global Head-New Technology at Novartis Corp.
from 2001 to 2005.
Furthermore, he held the position of Principal at Reed & Carnrick Pharmaceuticals.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/03/2024 | 984 476 ( 1.09% ) | 4 M $ | 31/03/2024 |
Posizioni attive di A. Schobel
Società | Posizione | Inizio |
---|---|---|
AQUESTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2014 |
MonoSol LLC /Laundry Bag Business/ | Investor Relations Contact | - |
Cecilian Partners, LLC
Cecilian Partners, LLC Packaged SoftwareTechnology Services Cecilian Partners LLC is a proptech company that collaborates with land developers and homebuilders to modernize their digital footprint and simplify the complexities of placemaking. The private company is based in New Hope, PA and has subsidiaries in the United States. Since 2019, the company has been offering real estate management, mapping, and development software to support property developers, home builders, and realtors. The company's patented technology platform includes 3D mapping technology and data management solutions that ease everyday pain points associated with building and buying homes. The company was founded in 2019 by John Cecilian and Philip Worland, with John Cecilian serving as the CEO since then. | Director/Board Member | - |
Precedenti posizioni note di A. Schobel
Società | Posizione | Fine |
---|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Reed & Carnrick Pharmaceuticals | Corporate Officer/Principal | - |
Pharmaceutical Formulations, Inc. | Corporate Officer/Principal | - |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Pharmaceutical Formulations, Inc. | Health Technology |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
MonoSol LLC /Laundry Bag Business/ | Process Industries |
Reed & Carnrick Pharmaceuticals | |
Cecilian Partners, LLC
Cecilian Partners, LLC Packaged SoftwareTechnology Services Cecilian Partners LLC is a proptech company that collaborates with land developers and homebuilders to modernize their digital footprint and simplify the complexities of placemaking. The private company is based in New Hope, PA and has subsidiaries in the United States. Since 2019, the company has been offering real estate management, mapping, and development software to support property developers, home builders, and realtors. The company's patented technology platform includes 3D mapping technology and data management solutions that ease everyday pain points associated with building and buying homes. The company was founded in 2019 by John Cecilian and Philip Worland, with John Cecilian serving as the CEO since then. | Technology Services |
- Borsa valori
- Insiders
- A. Schobel